Table 1.
Study | Data sources | Cancer survivor population |
Geographic setting |
Cancer patient identification |
Time frame of costs |
Cost by service type | Individual conditions examined |
Multiple chronic conditions |
---|---|---|---|---|---|---|---|---|
Bernard et al. [24] | 2001–2008 MEPS, and 2001–2008 NHIS-MEPS linked sample | 4243 adults aged 18–64 years reporting any cancer diagnosis/receiving cancer treatment | National | Self-report | 1 year | Yes (0, 1+) | ||
Boltz et al. [25] | 1995–2005 SEER Medicare | 2823 adults aged ≥65 years with a differentiated thyroid cancer diagnosis | National | Registry | 1 and 5-year costs following diagnosis | Yes (0, 1 or 2, 3+) | ||
Cohen et al. 2003 [26] | 1997 MEPS | Adults aged ≥18 years with medical expenditures for any cancer. Sample size not provided. | National | Self-report | 1 year | Inpatient, ambulatory, prescription drugs, home health care | Yes (1, 2, 3) | |
Davidoff et al. [27] | 1997–2007 MCBS linked to Medicare claims | 1868 Medicare beneficiaries aged >65 years with any cancer diagnosis | National | Claims | 2 year following identification | Yes (0–1, 2–4, 5–8, ≥9) | ||
Forde et al. [28] | 1992–2009 SEER Medicare | 4506 women aged ≥65 years with an ovarian cancer diagnosis who underwent PDS or NACT | National | Registry/Claims | 7-months after PDS or NACT | Yes (0, 1, 2+) | ||
Han et al. [29] | 2008–2010 MEPS | 4326 adults aged ≥18 years with any cancer ever diagnosed | National | Self-report | 1 year | Serious psychological distress | ||
Hollenbeak et al. [32] | 1984–1994 SEER Medicare | 1780 Medicare beneficiaries with head and neck cancer diagnosisa | National | Registry | 1 and 5-year costs | Yes (WUHNCCI) | ||
Hollenbeak et al. [31] | 1995–2002 SEER Medicare | 4938 Medicare beneficiaries with renal cell carcinoma ever diagnoseda | National | Registry | 1 and 5-year costs following diagnosis | Anemia, hyperlidemia | Yes (CCI) | |
Hollenbeak et al. [30] | 1995–2005 SEER Medicare | 10711 Medicare beneficiaries aged ≥66 years with oral cavity (n = 6724) or pharyngeal cancer (n = 3987) ever diagnosed | National | Registry | 5-year costs following diagnosis | Yes (0, 1–2, 3+) | ||
Luo et al. [33] | 1996–2000 Michigan Medicaid and Medicare data merged with the Michigan Tumor Registry | 6462 Medicare beneficiaries aged ≥66 years (765 were also insured by Medicaid) with colon cancer diagnosis | Single state (Michigan) | Registry | 1 year following diagnosis | Yes (0, 1, 2, 3+) | ||
Pan et al. [34] | 2006–2009 MEPS | 4766 adults aged ≥21 years with any cancer | National | Self-report | 1 year costs | Inpatient, outpatient, prescription drugs, emergency department, otherb | Depression | |
Subramanian et al. [21] | 2000–2003 Medicaid administrative data linked to cancer registry data | 6212 Medicaid beneficiaries aged 21–64 years with any cancer diagnosis | Multiple states (Georgia, Maine, and Illinois) | Registry | 0–6 months following diagnosis | Hospital stays, ambulatory care services, prescription drugs, long-term care | Cardiac, Respiratory, Diabetes, Mental Health | Yes (1, 2, 3–4) |
MEPS: Medical Expenditure Panel Survey; NHIS: National Health Interview Survey; SEER: surveillance, epidemiology, end result; CCI: Charlson Comorbidity Index; WUHNCCI: Washington University Head and Neck Cancer Comorbidity Index; PDS: primary debulking surgery; NACT: neo-adjuvant chemotherapy; MCBS: Medicare Current Beneficiary Survey.
The age of Medicare beneficiaries included could not be ascertained from the published article; we assume aged ≥66 years.
Other expenditures include home health care, dental, vision, durable medical equipment, and other miscellaneous items.